Biotech Leadership Shift: How Edesa’s New CFO Could Shape the Future
Edesa Biotech announces Peter J. Weiler as its incoming Chief Financial Officer, effective May 1, 2025. Weiler transitions from his role as President of Exzell Pharma, bringing strategic expertise in…
The Strategic Shift at Edesa Biotech: A New Financial Navigator Takes the Helm
Edesa Biotech announces a leadership change, appointing Peter J. Weiler as Chief Financial Officer, effective May 1, 2025. Weiler's strategic and industry expertise, bolstered by roles at Exzell Pharma and…
Meet the New Financial Maestro Behind Edesa Biotech’s Strategic Evolution
Edesa Biotech announces Peter J. Weiler as the new CFO, signifying a strategic leadership shift. Weiler brings extensive experience in finance, biology, and business from his roles at Exzell Pharma,…
The Bold New Financial Move at Edesa Biotech: What It Means for the Future
Edesa Biotech has announced a strategic leadership change, appointing Peter J. Weiler as Chief Financial Officer effective May 1, 2025. Weiler brings extensive experience from roles at Exzell Pharma, Biosyent…
A New Chapter for Edesa Biotech: A Fresh Financial Leader Emerges
Edesa Biotech appoints Peter J. Weiler as Chief Financial Officer, effective May 1, 2025, marking a significant leadership change. Weiler succeeds Stephen Lemieux, who transitions to an advisory role, maintaining…
Why Edesa Biotech’s Latest Leadership Move Could Be a Game Changer
Edesa Biotech undergoes a pivotal leadership change as Peter J. Weiler replaces Stephen Lemieux. Weiler brings extensive experience from leadership roles at Exzell Pharma, Biosyent Inc., and Cipher Pharmaceuticals. His…
The Strategic Shift at Edesa Biotech: A New CFO Heralds a New Era
Peter J. Weiler is appointed CFO of Edesa Biotech starting May 1, 2025, marking a strategic leadership transition. Weiler brings extensive experience from roles in biotech and pharmaceuticals, previously as…
The Surprising Financial Maestro Set to Propel Edesa Biotech into a New Era
Edesa Biotech appoints Peter J. Weiler as Chief Financial Officer, signaling strategic financial enhancement amidst leadership transitions. Weiler's extensive experience in biotech and pharmaceuticals, highlighted by his role at Exzell…
The Surprising Leadership Change at Edesa Biotech: What It Means for the Future
Edesa Biotech appoints Peter J. Weiler as CFO starting May 1, 2025, succeeding Stephen Lemieux. Weiler brings extensive experience from leadership roles at Exzell Pharma and Biosyent Inc., blending scientific…
Meet the New Financial Maverick Guiding Edesa’s Future
Edesa Biotech announces Peter J. Weiler as the new CFO, effective May 1, 2025, signaling a pivotal shift in financial strategy. Weiler's extensive experience in the biotech and pharma sectors,…